How do I find out if I qualify for a early stage triple-negative breast carcinoma study in Georgia?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Georgia to take part?

Not necessarily. These studies have a site in Georgia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a early stage triple-negative breast carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Georgia

Early Stage Triple-Negative Breast Carcinoma clinical trials in Georgia

We’re tracking 4 recruiting early stage triple-negative breast carcinoma studies with a site in Georgia — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Georgia

NCT05812807RecruitingPhase 3
Pembrolizumab versus monitoring after triple-negative breast cancer response
This trial checks whether giving pembrolizumab (an immunotherapy) after surgery helps people with triple-negative breast cancer reduce the chance of the cancer coming back, compared with close monitoring only. It’s for patients who had no remaining invasive cancer after neoadjuvant chemotherapy plus pembrolizumab.
Albany, GeorgiaAges 18 years+
NCT05929768RecruitingPhase 3
Shorter chemo plus immunotherapy without anthracyclines for early TNBC
This Phase 3 trial tests whether a shorter course of chemotherapy plus immunotherapy can work as well as standard treatment for early-stage triple-negative breast cancer. It avoids anthracycline drugs and may help reduce exposure to those medicines if the shorter plan is effective and safe.
Decatur, GeorgiaAges 18 years+
NCT06324240RecruitingPhase 1
Personalized vaccine plus immunotherapy for triple-negative breast cancer
This trial tests a personalized vaccine made from your tumor combined with immunotherapy drugs (pembrolizumab or ipilimumab) for triple-negative breast cancer. It aims to help your immune system recognize and attack cancer cells.
Atlanta, GeorgiaAges 18 years+
NCT06492759RecruitingPhase 2
High-dose radiation with pembrolizumab and chemo for pd-l1 positive tnbc
This trial tests giving high-dose radiation along with the immunotherapy drug pembrolizumab and chemo to people with a specific subtype of advanced breast cancer (PD-L1 positive triple negative). It may help shrink tumors and keep them from growing.
Atlanta, GeorgiaAges 18 years+

Early Stage Triple-Negative Breast Carcinoma trials by city in Georgia

Atlanta

Where these studies are running in Georgia

Institutions with a site for the recruiting early stage triple-negative breast carcinoma studies listed above.

Emory University · 4 studies
Grady Health System · 3 studies
Augusta Oncology Associates PC-D'Antignac · 2 studies
Augusta Oncology Associates PC-Wheeler · 2 studies
Emory Decatur Hospital · 2 studies
Emory Johns Creek Hospital · 2 studies
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · 2 studies
Lewis Hall Singletary Oncology Center

What taking part in a early stage triple-negative breast carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Early Stage Triple-Negative Breast Carcinoma trials in other states

Common questions

Are there early stage triple-negative breast carcinoma clinical trials in Georgia?: Yes. We're currently tracking 4 recruiting early stage triple-negative breast carcinoma studies with a site in Georgia, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a early stage triple-negative breast carcinoma study in Georgia?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Georgia to take part?: Not necessarily. These studies have a site in Georgia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a early stage triple-negative breast carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New early stage triple-negative breast carcinoma studies open in Georgia regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.